According to Clinuvel Pharmaceuticals's latest financial reports the company's total assets are โน13.37 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-06-30 | โน10.52 B | 34.68% |
2022-06-30 | โน7.81 B | 28.95% |
2021-06-30 | โน6.05 B | 42.86% |
2020-06-30 | โน4.24 B | 40.53% |
2019-06-30 | โน3.01 B | 38.85% |
2018-06-30 | โน2.17 B | 52.63% |
2017-06-30 | โน1.42 B | 40.44% |
2016-06-30 | โน1.01 B | 52.02% |
2015-06-30 | โน0.66 B | -31.21% |
2014-06-30 | โน0.96 B | 12.7% |
2013-06-30 | โน0.86 B | -5.38% |
2012-06-30 | โน0.90 B | -5.77% |
2011-06-30 | โน0.96 B | -16.21% |
2010-06-30 | โน1.15 B | -28.17% |
2009-06-30 | โน1.60 B | -28.94% |
2008-06-30 | โน2.25 B | -3.05% |
2007-06-30 | โน2.32 B | 300.79% |
2006-06-30 | โน0.58 B | 74.17% |
2005-06-30 | โน0.33 B | 2.68% |
2004-06-30 | โน0.32 B | 30.05% |
2003-06-30 | โน0.24 B | -13.49% |
2002-06-30 | โน0.28 B | -12.87% |
2001-06-30 | โน0.33 B |